Login / Signup

Impact of different dose reduction criteria for anti-Xa direct oral anticoagulants on bleeding complications: A single center observational study.

Hidehira FukayaJun OikawaHironori NakamuraTazuru IgarashiTamami FujiishiNaruya IshizueTomoharu YoshizawaAkira SatohJun KishiharaShinichi NiwanoJunya Ako
Published in: Journal of arrhythmia (2022)
The patients with a standard dose of Apix had a higher incidence of minor bleeding events than the other dosages. A reduced dose of apixaban was not prone to being chosen because of the dose reduction criteria, which may have been associated with a higher minor bleeding rate in patients with Apix.
Keyphrases
  • atrial fibrillation
  • direct oral anticoagulants
  • venous thromboembolism
  • risk factors